13F-HR/A filed by RA CAPITAL MANAGEMENT, L.P.
RA CAPITAL MANAGEMENT, L.P. filed this 13F-HR/A for the quarter ended 2015-03-31, filed 2015-07-06, with 57 holding rows worth $1,006,949,000.
- Accession
- 0001144204-15-041113
- Filer
- CIK 1346824
- Filed
- 2015-07-06
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q1 2015
A holdings report, amendment of type restatement, 57 entries on the cover page, a total value of $1,006,949,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $1,006,949,000 with VALUE read as thousands by filing date, 13F file number 028-12884. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| SANGAMO THERAPEUTICS INC | 800677106 | COM | 6,000,000 | $94,080,000 | thousands by filing date | call |
| ACHILLION PHARMACEUTICALS IN | 00448Q201 | COM | 8,207,530 | $80,926,000 | thousands by filing date | |
| DYAX CORP | 26746E103 | COM | 4,207,594 | $70,498,000 | thousands by filing date | |
| BIOCRYST PHARMACEUTICALS INC COM | 09058V103 | Stock | 6,926,617 | $62,547,000 | thousands by filing date | |
| REGULUS THERAPEUTICS INC | 75915K101 | COM | 3,590,688 | $60,826,000 | thousands by filing date | |
| DICERNA PHARMACEUTICALS INC | 253031108 | COM | 2,428,571 | $58,359,000 | thousands by filing date | |
| DYNAVAX TECHNOLOGIES CORP | 268158201 | COM NEW | 2,600,000 | $58,318,000 | thousands by filing date | |
| TG THERAPEUTICS INC COM | 88322Q108 | Stock | 3,125,149 | $48,377,000 | thousands by filing date | |
| COHERUS ONCOLOGY INC | 19249H103 | COM | 1,555,355 | $47,563,000 | thousands by filing date | |
| TEKMIRA PHARMACEUTICALS COR | 87911B209 | COM NEW | 2,714,800 | $47,400,000 | thousands by filing date | |
| XENCOR INC | 98401F105 | COMMON STOCK | 2,149,423 | $32,929,000 | thousands by filing date | |
| ZAFGEN INC | 98885E103 | COM | 732,960 | $29,033,000 | thousands by filing date | |
| BLUEBIRD BIO INC | 09609G100 | COM | 200,379 | $24,200,000 | thousands by filing date | |
| BELLICUM PHARMACEUTICALS INC | 079481107 | COM | 1,026,402 | $23,782,000 | thousands by filing date | |
| ZS PHARMA INC | 98979G105 | Common Stock | 564,483 | $23,753,000 | thousands by filing date | |
| SANGAMO THERAPEUTICS INC | 800677106 | COM | 1,220,209 | $19,133,000 | thousands by filing date | |
| ASCENDIS PHARMA A/S DKK 1.0 AD | 04351P101 | SPONSORED ADR | 1,023,652 | $17,760,000 | thousands by filing date | |
| JUNO THERAPEUTICS INC | 48205A109 | COM | 280,000 | $16,985,000 | thousands by filing date | |
| OMEROS CORP | 682143102 | COM | 749,000 | $16,500,000 | thousands by filing date | |
| PROTEON THERAPEUTICS INC | 74371L109 | COM | 1,250,000 | $14,538,000 | thousands by filing date | |
| AGILE THERAPEUTICS INC | 00847L100 | COM | 1,458,792 | $13,523,000 | thousands by filing date | |
| NOVAVAX INC | 670002104 | COMMON STOCK | 1,431,232 | $11,836,000 | thousands by filing date | |
| THERAPEUTICSMD INC | 88338N107 | COM | 1,680,395 | $10,166,000 | thousands by filing date | |
| ARRAY BIOPHARMA INC COM | 04269X105 | Stock | 1,357,584 | $10,005,000 | thousands by filing date | |
| CONCERT PHARMACEUTICALS INC | 206022105 | COM | 660,000 | $9,996,000 | thousands by filing date | |
| OREXIGEN THERAPEUTICS INC | 686164104 | COMMON STOCK | 1,186,229 | $9,288,000 | thousands by filing date | |
| TENAX THERAPEUTICS INC | 88032L100 | COM | 2,670,300 | $8,705,000 | thousands by filing date | |
| TREVENA INC | 89532E109 | COM | 1,325,407 | $8,642,000 | thousands by filing date | |
| SUCAMPO PHARMACEUTICALS-CL A | 864909106 | CL A | 450,000 | $7,002,000 | thousands by filing date | |
| AKEBIA THERAPEUTICS INC | 00972D105 | COMMON STOCK | 597,363 | $6,637,000 | thousands by filing date | |
| VICAL INC | 925602104 | COM | 7,024,274 | $6,637,000 | thousands by filing date | |
| AURINIA PHARMACEUTICALS INC COM | 05156V102 | Stock | 1,504,776 | $6,561,000 | thousands by filing date | |
| SCYNEXIS INC COM NEW | 811292101 | Common Stock | 789,097 | $6,550,000 | thousands by filing date | |
| AURIS MED HLDG AG | H03579101 | COM | 940,000 | $5,029,000 | thousands by filing date | |
| VERSARTIS INC | 92529L102 | COM | 231,267 | $4,248,000 | thousands by filing date | |
| TROVAGENE INC | 897238309 | COM | 594,200 | $4,047,000 | thousands by filing date | |
| BIOTA PHARMACEUTIALS INC | 090694100 | COM | 1,403,853 | $3,229,000 | thousands by filing date | |
| ROCKWELL MED INC | 774374102 | COM | 250,207 | $2,735,000 | thousands by filing date | |
| TTOO | 89853L104 | Stock | 138,002 | $2,142,000 | thousands by filing date | |
| OCERA THERAPEUTICS INC COM | 67552A108 | COM | 417,476 | $1,966,000 | thousands by filing date | |
| ONCOTHYREON INC | 682324108 | COM | 1,165,765 | $1,900,000 | thousands by filing date | |
| AGIOS PHARMACEUTICALS INC | 00847X104 | COM | 17,600 | $1,660,000 | thousands by filing date | |
| NEWLINK GENETICS CORP | 651511107 | COM | 30,000 | $1,641,000 | thousands by filing date | |
| PTC THERAPEUTICS INC | 69366J200 | COM | 25,800 | $1,570,000 | thousands by filing date | |
| MERRIMACK PHARMACEUTICALS IN | 590328100 | COM | 116,400 | $1,383,000 | thousands by filing date | |
| REPLIGEN CORP COM | 759916109 | Stock | 45,000 | $1,366,000 | thousands by filing date | |
| TESARO INC | 881569107 | COM | 23,500 | $1,349,000 | thousands by filing date | |
| ALKERMES PLC | G01767105 | SHS | 19,200 | $1,171,000 | thousands by filing date | |
| WAFERGEN BIO-SYSTEMS INC | 93041P308 | Cmn | 255,400 | $1,157,000 | thousands by filing date | |
| REGENERON PHARMACEUTICALS COM | 75886F107 | Stock | 2,450 | $1,106,000 | thousands by filing date | |
| BIOGEN INC COM | 09062X103 | Stock | 2,600 | $1,098,000 | thousands by filing date | |
| CELGENE CORP | 151020104 | COM | 8,700 | $1,003,000 | thousands by filing date | |
| Amgen Inc. | 031162100 | COM | 5,900 | $943,000 | thousands by filing date | |
| ACADIA PHARMACEUTICALS INC | 004225108 | COM | 27,300 | $890,000 | thousands by filing date | |
| CELLADON CORP | 15117E107 | Cmn | 40,900 | $775,000 | thousands by filing date | |
| KERYX BIOPHARMACEUTICALS | 492515101 | COMMON STOCK | 59,200 | $754,000 | thousands by filing date | |
| PUMA BIOTECHNOLOGY INC | 74587V107 | COMMON STOCK | 3,100 | $732,000 | thousands by filing date |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001144204-15-031600 | superseded | 2015-05-15 | acceptance time not in the bulk data set | |
| 13F-HR/A 0001144204-15-041113 | this filing | 2015-07-06 | acceptance time not in the bulk data set |